Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-3165-2026

NOXBOX LTD recalls NOxBOXi Nitric Oxide Delivery System.

NOXBOX LTDSittingbourne, United KingdomReported Sep 23, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

Potential for oxygen tubing leaks due to failure of the tubing or tubing connection, which may lead to oxygen desaturation.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • NOxBOXi Nitric Oxide Delivery SystemUDI
    UDI-DI 05060541640009.
    400 affected lots
    NM100825NM100833NM100839NM100840NM100841NM100847NM100848NM100849
    +392 moreNM100850NM100851NM100852NM100855NM100858NM100859NM100861NM100862NM100865NM100866NM100868NM100869NM100872NM100873NM100875NM100876NM100878NM100879NM100880NM100881NM100882NM100883NM100884NM100885NM100886NM100887NM100888NM100895NM100932NM100935NM100942NM100948NM100949NM100953NM100961NM100975NM100976NM100978NM100980NM100983NM100985NM100986NM100987NM100989NM100990NM100991NM100993NM100994NM100996NM100997NM100999NM101001NM101002NM101003NM101004NM101005NM101006NM101008NM101009NM101010NM101011NM101012NM101013NM101014NM101015NM101017NM101018NM101019NM101024NM101026NM101028NM101029NM101030NM101031NM101033NM101034NM101035NM101038NM101039NM101041NM101042NM101044NM101048NM101049NM101052NM101057NM101059NM101060NM101061NM101063NM101065NM101067NM101069NM101071NM101072NM101073NM101077NM101079NM101080NM101081NM101083NM101084NM101086NM101088NM101089NM101090NM101091NM101092NM101093NM101094NM101095NM101099NM101100NM101101NM101105NM101106NM101107NM101108NM101109NM101110NM101111NM101112NM101113NM101114NM101115NM101116NM101117NM101125NM101130NM101131NM101132NM101133NM101134NM101135NM101136NM101137NM101138NM101141NM101142NM101144NM101145NM101146NM101147NM101148NM101149NM101150NM101151NM101153NM101154NM101155NM101156NM101158NM101159NM101160NM101161NM101162NM101163NM101164NM101165NM101167NM101168NM101170NM101173NM101174NM101175NM101176NM101177NM101178NM101179NM101180NM101181NM101182NM101183NM101184NM101190NM101191NM101192NM101199NM101202NM101204NM101205NM101207NM101208NM101209NM101211NM101212NM101213NM101214NM101215NM101216NM101217NM101218NM101219NM101220NM101221NM101222NM101223NM101224NM101225NM101227NM101228NM101229NM101230NM101231NM101232NM101233NM101234NM101236NM101237NM101241NM101243NM101244NM101245NM101246NM101249NM101250NM101251NM101252NM101253NM101254NM101255NM101256NM101257NM101258NM101259NM101263NM101264NM101265NM101266NM101268NM101270NM101271NM101273NM101278NM101282NM101284NM101285NM101286NM101287NM101288NM101289NM101292NM101294NM101295NM101297NM101298NM101299NM101300NM101301NM101303NM101305NM101307NM101308NM101309NM101313NM101314NM101317NM101321NM101322NM101323NM101324NM101326NM101327NM101328NM101329NM101330NM101331NM101333NM101335NM101336NM101337NM101338NM101340NM101342NM101344NM101346NM101347NM101349NM101350NM101351NM101353NM101354NM101355NM101356NM101357NM101359NM101360NM101361NM101368NM101372NM101373NM101376NM101377NM101379NM101380NM101381NM101384NM101386NM101387NM101388NM101390NM101392NM101393NM101394NM101395NM101396NM101402NM101404NM101405NM101406NM101407NM101408NM101409NM101410NM101411NM101412NM101413NM101414NM101415NM101416NM101423NM101425NM101426NM101428NM101429NM101430NM101431NM101432NM101433NM101434NM101435NM101436NM101437NM101439NM101441NM101442NM101443NM101444NM101446NM101448NM101449NM101451NM101452NM101454NM101456NM101457NM101459NM101460NM101461NM101462NM101463NM101464NM101467NM101468NM101469NM101472NM101473NM101474NM101475NM101478NM101479NM101482NM101483NM101484NM101485NM101486NM101487NM101489NM101490NM101491NM101492NM101496NM101505NM101506NM101508NM101509NM101512NM101514NM101515NM101516NM101520NM101521NM101522NM101524NM101525NM101526NM101527NM101529NM101530NM101532NM101533NM101540

What the firm is doing

NOxBOX notified its single US distributor on about 08/19/2026 via emailed "URGENT MEDICAL DEVICE CORRECTION" letter. Consignees were informed of the issue of potential oxygen leaks within the NOxMixer module of the NOxBOXi device due to failure of the tubing or tubing connection. This may lead to interruption in nitric oxide therapy, which could lead to oxygen desaturation and necessitate medical intervention. Distributors were instructed to examine inventory for affected units, complete and return the Distributor Response Form provided and NOxBOX will provide work instructions and material to complete the NOxMixer repairs. Before distributing any affected devices, perform all preventive maintenance checks on NOxBOXi devices. Those that have passed all preventive maintenance checks can continue to be distributed with a copy of this notice. Devices that do not pass must be quarantined until remediated. Distributors were also instructed to notify all affected customers and applicable personnel. Users of the device were instructed to examine inventory for affected, complete and return the Customer Response form provided, and provide the notification to all those who need to be made aware within the organization or to any organization where the potentially affected devices have been transferred or for which this action has an impact. Customers should ensure that all personnel using the device are provided with a copy of the recommendations in Attachment D and post them near the device. NOxBOX has developed a replacement for the tubing and tubing connection and will be working with distributors to implement for their affected devices. Further details will be provided to distributors to ensure all upgrades are successfully completed. In addition, NOxBOX is implementing an update to the NOxBOXi + NOxMixer Service Manual to include inspection of the NOxMixer internal oxygen tubing and tubing connection for replacement as part of the preventative maintenance (PM) sche

DistributionShow details

US Nationwide distribution in the state of Georgia.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls